Skip to content

Medical-device intelligence

GGT: Assay, Erythropoietin

FDA product code GGT: Assay, Erythropoietin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GGT
FDA device name
Assay, Erythropoietin
Device class
2
Regulation number
864.7250
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

20 clearance records and 5 recall records in the covered releases, across 14 source company names and 1 product codes. Dated history runs from Mar 23, 1984 to Feb 3, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GGT · Assay, Erythropoietin205

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

25 matching records
Device / recordCompany in FDA recordSourceSource date
Access Erythropoietin (EPO), Catalog Number - A16364 a glycoprotein (~30,400 Daltons) produced primarily by the kidney, is the principal factor r…Z-1249-2025 · GGTBeckman Coulter, Inc.RecallFeb 28, 2025FDA classification date
Access EPOK240182 · GGTBeckman Coulter, Inc.510(k)Apr 22, 2024FDA decision date
Atellica IM Erythropoietin (EPO) Assay (100 Test)Z-1280-2024 · GGTSiemens Healthcare Diagnostics, Inc.RecallMar 11, 2024FDA classification date
ADVIA Centaur Erythropoietin (EPO) Assay (100 Test)Z-1281-2024 · GGTSiemens Healthcare Diagnostics, Inc.RecallMar 11, 2024FDA classification date
Quantikine IVD Erythropoietin Human Serum Controls for use as quantitative controls for the determination of Erythropoietin concentrations in hum…Z-1390-2022 · GGTR & D Systems, Inc.RecallJul 15, 2022FDA classification date
ADVIA Centaur Erythropoietin (EPO) assayK183088 · GGTAxis-Shield Diagnostics Limited510(k)Aug 2, 2019FDA decision date
ACCESS EPO ASSAYK052223 · GGTBeckman Coulter, Inc.510(k)Oct 6, 2006FDA decision date
Nichols Advantage EPO Calibration Verifiers, Catalog #63-7512Z-0136-06 · GGTNichols Institute DiagnosticsRecallNov 15, 2005FDA classification date
SANGUI BIOTECH, INC. EPO (ERYTHROPOIETIN) ELISA KITK992799 · GGTSangui Biotech, Inc.510(k)Jun 7, 2000FDA decision date
IMMULITE EPO, MODEL #'S LKEPZ & LKEP1K983203 · GGTDiagnostic Products Corp.510(k)Jul 12, 1999FDA decision date
ADVANTAGE CHEMILUMINESCENCE ERYTHROPOIETIN IMMUNOASSAYK980737 · GGTNichols Institute Diagnostics510(k)Mar 23, 1999FDA decision date
ERYTHROPOIETIN IMMUNOASSAY KITK952559 · GGTNichols Institute510(k)May 29, 1996FDA decision date
PREDICTA ERYTHROPOIETIN KIT (MODIFICATION)K954898 · GGTGenzyme Corp.510(k)Feb 5, 1996FDA decision date
QUANTIKINE IVD ERYTHROPOIETIN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)K936016 · GGTR&D Systems, Inc.510(k)Jul 19, 1994FDA decision date
QUANTIKINE(TM) ERYTHROPOIETIN HUMAN SERUM CONTROLSK931756 · GGTR&D Systems, Inc.510(k)Apr 21, 1994FDA decision date
ERYTHROPOIETIN IMMUNOASSAY KITK932650 · GGTNichols Institute510(k)Mar 11, 1994FDA decision date
QUANTIKINE(TM) ERYTHROPOIETIN/ENZ LINK IMMUN ASSAYK931666 · GGTR&D Systems, Inc.510(k)Jul 20, 1993FDA decision date
PREDICTA ERYTHROPOIETIN KITK926390 · GGTGenzyme Corp.510(k)Jun 25, 1993FDA decision date
EPO-RIAK910481 · GGTRamco Laboratories, Inc.510(k)Nov 29, 1991FDA decision date
DSL ERYTHROPOIETIN (DSL # 1100)K903492 · GGTDiagnostic Systems Laboratories, Inc.510(k)Oct 26, 1990FDA decision date
EPO-TRAC(TM) 125I RADIOIMMUNOASSAY (RIA)K902639 · GGTIncstar Corp.510(k)Aug 22, 1990FDA decision date
EPO-TRAC BY RADIOIMMUNOASSAY (RIA)K893393 · GGTIncstar Corp.510(k)Nov 21, 1989FDA decision date
CLINIGEN ERYTHROPOIETIN HUMAN SERUM CONTROLS 1,2,3K894943 · GGTAmgen, Inc.510(k)Oct 10, 1989FDA decision date
ERYTHROPOIETIN ENZYME IMMUNOASSAYK882686 · GGTAmgen, Inc.510(k)Dec 20, 1988FDA decision date
ERYTHROPOIETIN EIAK833957 · GGTJcl Clinical Research Corp.510(k)Mar 23, 1984FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗